Results 141 to 150 of about 104,093 (313)

Cost burden and temporal trends of herpes zoster in China: Evidence from Beijing's health records

Preventive Medicine Reports
Objective: Herpes zoster poses a significant health threat to the aging population in China. This study aimed to analyze the cost burden and temporal trends of herpes zoster in China.
Zhenyu Shi, Feng Lu, Yiqi Xia, Ping He
doaj   +1 more source

Иммуномодуляторы в комплексной терапии опоясывающего герпеса [PDF]

, 2014
Оценка клинической эффективности комплексной стандартной терапии пациентов с Herpes Zoster, включающей валацикловир, и комплекной терапии, включающей иммуномодуляторы иммуномакс и ...
Бибичева, Т. В., Попов, В. Е., Провоторов, В. Я., Рогова, Ю. А., Харахордина, Ю. Е.   +4 more
core   +1 more source

Clinical Features of Herpes Zoster in Children according to Immune Status [PDF]

, 2018
최영빈, 권영세, 김동현
openalex   +1 more source

Necrotizing Fasciitis After Herpes Zoster Infection: A Rare Case With Diagnostic Difficulties [PDF]

, 2022
Bilgen Can, Betül Gözel
openalex   +1 more source

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin, Marie Tauber, Robert Sidbury, Jonathan I. Silverberg, Kim A. Papp, Diamant Thaçi, Marjolein S. De Bruin‐Weller, Adam Reich, Ketty Peris, Kirk Barber, Ryszard Galus, Andrzej Kaszuba, Matthew Zirwas, Walter K. Nahm, Gretel Trullenque, Laura Maintz, Sady Alpizar, Sang Wook Son, Vivian Laquer, Linda Stein Gold, Soo Yeon Cheong, Anna Ryzhkova, Agnes Drahos, Liliana Ulianov, Christophe Piketty   +24 more
wiley   +1 more source

Herpes zoster

Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2021
openaire   +3 more sources

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The current study found no evidence of cumulative increased safety risks with upadacitinib 15 or 30 mg for up to 6 years and over 9000 patient‐years of safety data in adults and adolescents. There were low rates of adjudicated major adverse cardiovascular events, adjudicated thromboembolic events and malignancies. Abstract Background Atopic dermatitis (
Christopher G. Bunick, Alan D. Irvine, Jonathan I. Silverberg, Emma Guttman‐Yassky, Mona Shahriari, Xinghua Gao, Stephan Weidinger, Norito Katoh, Namita Vigna, Deanne M. Dilley, Elvira D'Andrea, Henrique D. Teixeira, Andrew M. Platt, Gweneth F. Levy   +13 more
wiley   +1 more source

Herpes Zoster In A 3 Month Old Infant

Indian Journal of Dermatology, 1998
A case of herpes zoster in a 3 month old female infant is reported. The patient suffered from varicella 1 month prior to onset of herpes zoster, following varicella of mother.
Gangopadhyay D N, Barbhuiya J N, Dey S K
doaj  

The dysregulation of innate immunity by Porphyromonas gingivalis in the etiology of Alzheimer's disease

Journal of Internal Medicine, EarlyView.
Abstract The etiology of Alzheimer's disease (AD) remains under active debate. In this perspective, we explore the hypothesis that a primarily infection‐caused chronic dysregulation and weakening of human innate immunity via the underexpression, degradation, and inactivation of innate immune proteins necessary for direct antimicrobial effects and ...
Annelise E. Barron, Jennifer S. Lin, Mark I. Ryder, Peter Bergman   +3 more
wiley   +1 more source